South Korea · Delayed Price · Currency is KRW MEDIPOST Statistics
Total Valuation
MEDIPOST has a market cap or net worth of KRW 791.48 billion. The enterprise value is 754.74 billion.
| Market Cap | 791.48B |
| Enterprise Value | 754.74B |
Important Dates
The last earnings date was Friday, April 3, 2026.
| Earnings Date | Apr 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDIPOST has 39.09 million shares outstanding. The number of shares has increased by 4.03% in one year.
| Current Share Class | 39.09M |
| Shares Outstanding | 39.09M |
| Shares Change (YoY) | +4.03% |
| Shares Change (QoQ) | +32.35% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 0.35% |
| Float | 20.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.75 |
| PB Ratio | 3.17 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.84 |
| EV / Sales | 10.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.57 |
Financial Position
The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.16.
| Current Ratio | 1.33 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.67 |
| Interest Coverage | -127.58 |
Financial Efficiency
Return on equity (ROE) is -30.68% and return on invested capital (ROIC) is -30.13%.
| Return on Equity (ROE) | -30.68% |
| Return on Assets (ROA) | -10.05% |
| Return on Invested Capital (ROIC) | -30.13% |
| Return on Capital Employed (ROCE) | -20.32% |
| Weighted Average Cost of Capital (WACC) | 7.82% |
| Revenue Per Employee | 228.75M |
| Profits Per Employee | -265.21M |
| Employee Count | 322 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.53 |
Taxes
In the past 12 months, MEDIPOST has paid 118.57 million in taxes.
| Income Tax | 118.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +167.50% in the last 52 weeks. The beta is 0.71, so MEDIPOST's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +167.50% |
| 50-Day Moving Average | 22,284.80 |
| 200-Day Moving Average | 16,146.20 |
| Relative Strength Index (RSI) | 46.42 |
| Average Volume (20 Days) | 258,267 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MEDIPOST had revenue of KRW 73.66 billion and -85.40 billion in losses. Loss per share was -2,408.00.
| Revenue | 73.66B |
| Gross Profit | 45.44B |
| Operating Income | -68.02B |
| Pretax Income | -85.87B |
| Net Income | -85.40B |
| EBITDA | -62.04B |
| EBIT | -68.02B |
| Loss Per Share | -2,408.00 |
Balance Sheet
The company has 78.03 billion in cash and 40.40 billion in debt, with a net cash position of 37.63 billion or 962.87 per share.
| Cash & Cash Equivalents | 78.03B |
| Total Debt | 40.40B |
| Net Cash | 37.63B |
| Net Cash Per Share | 962.87 |
| Equity (Book Value) | 249.91B |
| Book Value Per Share | 5,922.37 |
| Working Capital | 31.48B |
Cash Flow
In the last 12 months, operating cash flow was -57.15 billion and capital expenditures -2.92 billion, giving a free cash flow of -60.06 billion.
| Operating Cash Flow | -57.15B |
| Capital Expenditures | -2.92B |
| Depreciation & Amortization | 5.99B |
| Net Borrowing | 54.24B |
| Free Cash Flow | -60.06B |
| FCF Per Share | -1,536.65 |
Margins
Gross margin is 61.69%, with operating and profit margins of -92.35% and -115.94%.
| Gross Margin | 61.69% |
| Operating Margin | -92.35% |
| Pretax Margin | -116.59% |
| Profit Margin | -115.94% |
| EBITDA Margin | -84.22% |
| EBIT Margin | -92.35% |
| FCF Margin | n/a |
Dividends & Yields
MEDIPOST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.03% |
| Shareholder Yield | -4.03% |
| Earnings Yield | -10.79% |
| FCF Yield | -7.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 29, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Mar 29, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
MEDIPOST has an Altman Z-Score of 0.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.54 |
| Piotroski F-Score | 2 |